Revium Rx. (OTCPK: RVRC)
Health Care · Biotechnology · IL
$—
— today · — 1Y
Revium Rx. (OTCPK: RVRC) operates in the Biotechnology industry within the Health Care sector. The company is valued at $86.84M and employs 1 people.
trading between 1.05 and 1.67.
Tweenvest scores Revium Rx. across four factors: quality 50/100, value 47/100. Its strongest factor is quality.
RVRC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $86.84M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.22
- Dividend yield
- —
- Beta (5Y)
- -0.42
- 52-week high
- $1.67
- 52-week low
- $1.05
- Avg volume (3M)
- —
- Shares outstanding
- 60.73M
- Employees
- 1
- Next earnings
- —
About Revium Rx.
Operating from its Irvine, California headquarters, Revium Recovery Inc. is a United States-based entity engaged in the production and commercialization of an extensive portfolio of both alcoholic and non-alcoholic drinks. Its product catalog features a variety of specialized waters (structured and flavored), a selection of sports and energy beverages, green tea, and a range of spirits. The company also holds a significant strategic collaboration with Quantum TecH20. This enterprise, initially named OC Beverages, Inc., rebranded to Revium Recovery Inc. in December of 2020.
- ISIN
- US76151C1009
- Founded
- 1997
- Listed since
- Jul 26, 2010
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Conexeu Sciences Inc.NasdaqCM: CNXU | $87.44M | $3.64 | +17.42% |
| 3D Medicines Inc.SEHK: 1244 | $87.44M | HK$2.79 | +4.30% |
| Cardiff Oncology, Inc.NasdaqCM: CRDF | $87.13M | $1.09 | -2.68% |
| ReproCELL IncorporatedTSE: 4978 | $86.89M | ¥132.00 | -6.38% |
| Allied Biotech CorporationTPEX: 1780 | $86.80M | NT$25.35 | +2.63% |
| Acrivon Therapeutics, Inc.NasdaqGM: ACRV | $85.28M | $1.88 | -5.53% |
| BIOTON S.A.WSE: BIO | $84.01M | zł3.96 | +4.07% |
| Greenland Mines LtdNasdaqCM: GRML | $83.47M | $5.83 | -26.02% |
Figures last refreshed Oct 4, 2026.